BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+10.86%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$5.06B
AUM Growth
–
Cap. Flow
+$4.01B
Cap. Flow %
79.28%
Top 10 Hldgs %
79.91%
Holding
75
New
67
Increased
–
Reduced
–
Closed
–

Top Buys

1
PCYC
PHARMACYCLICS INC
PCYC
$856M
2
SGEN
Seagen Inc. Common Stock
SGEN
$608M
3
GHDX
Genomic Health, Inc.
GHDX
$433M
4
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$387M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
$362M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 39.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PCYC
1
DELISTED
PHARMACYCLICS INC
PCYC
$856M 16.93% +10,771,138 New +$856M
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
$608M 12.02% +19,322,947 New +$608M
GHDX
3
DELISTED
Genomic Health, Inc.
GHDX
$433M 8.56% +13,650,835 New +$433M
GEVA
4
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$387M 7.66% +9,223,182 New +$387M
ACAD icon
5
Acadia Pharmaceuticals
ACAD
$4.38B
$362M 7.16% +19,955,126 New +$362M
INCY icon
6
Incyte
INCY
$16.5B
$326M 6.44% +14,810,559 New +$326M
VPHM
7
DELISTED
VIROPHARMA INC
VPHM
$244M 4.83% +8,528,603 New +$244M
XOMA icon
8
Xoma
XOMA
$392M
$73.6M 1.46% +20,274,581 New +$73.6M
GILD icon
9
Gilead Sciences
GILD
$140B
$63.9M 1.26% +1,245,800 New +$63.9M
AEGR
10
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
$58.5M 1.16% +924,343 New +$58.5M
HALO icon
11
Halozyme
HALO
$8.56B
$52.1M 1.03% +6,553,150 New +$52.1M
RPRX
12
DELISTED
Repros Therapeutics Inc.
RPRX
$51.3M 1.01% +2,778,654 New +$51.3M
BMRN icon
13
BioMarin Pharmaceuticals
BMRN
$11.2B
$43.7M 0.86% +783,311 New +$43.7M
CERS icon
14
Cerus
CERS
$251M
$37.4M 0.74% +8,455,306 New +$37.4M
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
$35.2M 0.7% +525,113 New +$35.2M
VNDA icon
16
Vanda Pharmaceuticals
VNDA
$279M
$32M 0.63% +3,966,179 New +$32M
ARIA
17
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$25.4M 0.5% +1,450,000 New +$25.4M
STML
18
DELISTED
Stemline Therapeutics, Inc.
STML
$21.5M 0.42% +900,000 New +$21.5M
ICPT
19
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$20.8M 0.41% +462,847 New +$20.8M
MDVN
20
DELISTED
MEDIVATION, INC.
MDVN
$19.6M 0.39% +398,331 New +$19.6M
PGNX
21
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$18.7M 0.37% +4,200,000 New +$18.7M
DSCI
22
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$18.1M 0.36% +1,358,857 New +$18.1M
AVNR
23
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$16.5M 0.33% +3,578,591 New +$16.5M
INFI
24
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$16.5M 0.33% +1,016,433 New +$16.5M
QCOR
25
DELISTED
QUESTCOR PHARMA INC
QCOR
$14.4M 0.28% +315,846 New +$14.4M
1
2 3